The public issue will have a fresh issue of equity shares worth up to Rs 1,060 crore and sale of up to 63 lakh equity shares by Glenmark Pharma
With a flurry of excitement around new aged unicorns and interest garnered in IPOs, it appears India is moving towards a Private Market platform
The success of Zomato IPO and its listing has paved the way for more Indian unicorns to go public
Gujarat-based specialty chemical firm Tatva Chintan Pharma Chem is likely to finalise the share allocation on Monday
India has emerged as a stable destination for FDI and was even among the top five nations to attract such investments in the pandemic year
CLSA India, Credit Suisse Securities (India) and Jefferies India are the book running lead managers to the issue
The online insurance aggregator is seeking a valuation of $5 billion
As many as 25 firms have already raised over Rs 27,000 crore via the initial public offering route this year so far
GR Infraprojects and Clean Science & Technology both have strong balance sheets and industry-leading margin and return ratios
While there may be listing gains but at some point, there will be a massive correction so investors should be extremely cautious, says Bandyopahyay